Rapporto sull’analisi delle dimensioni del mercato e dell’analisi delle quote della tecnologia degli enzimi medici | Previsioni 2031

  • Report Code : TIPRE00020828
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 231
Buy Now

Si prevede che la tecnologia degli enzimi medici raggiungerà i 6.700,00 milioni di dollari entro il 2028 rispetto ai 4.012,57 milioni di dollari del 2020; si stima che crescerà a un CAGR del 6,7% dal 2021 al 2028.

Il mercato della tecnologia degli enzimi medici è stato analizzato sulla base del tipo di enzima, dell'applicazione e regione. Il mercato in base alla regione è segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Africa, America meridionale e centrale. Il rapporto sottolinea parametri quali tendenze di mercato, progressi tecnologici, dinamiche di mercato e analisi del panorama competitivo dell'azienda leader per offrire approfondimenti e analisi approfondite del mercato della tecnologia degli enzimi medici. Include anche l’analisi della pandemia COVID-19 nel mercato in tutte le regioni chiave.

Regioni redditizie per il mercato della tecnologia degli enzimi medici

Approfondimenti di mercato< /p>

I progressi nell'ingegneria enzimatica emergeranno come tendenza chiave nel mercato della tecnologia degli enzimi medici

L'ingegneria enzimatica svolge un ruolo fondamentale nello sviluppo di biocatalizzatori efficienti per la biotecnologia, le scienze della vita e la biomedicina. L'ingegneria enzimatica è il processo di personalizzazione di nuovi biocatalizzatori con proprietà migliorate alterando le loro sequenze di amminoacidi. Nonostante l'immensità delle possibili alterazioni, questa procedura ha già prodotto risultati notevoli sotto forma di progetti unici e ottimizzazione di enzimi per la biosintesi chimica e farmaceutica, la medicina rigenerativa, la produzione alimentare, la biodegradazione dei rifiuti e il biosensing.

A parte. dagli approcci di progettazione razionale classica e di evoluzione diretta, i metodi di apprendimento automatico (ML) vengono sempre più applicati per trovare modelli nei dati che aiutano a prevedere le strutture delle proteine; migliorare la stabilità, la solubilità e la funzione degli enzimi; prevedere la specificità del substrato; e guidare la progettazione razionale delle proteine. L’apprendimento automatico è un terzo approccio alla progettazione di nuovi biocatalizzatori, che ha guadagnato attenzione negli ultimi decenni. A differenza dei metodi di progettazione razionale basati su modelli, questa strategia è guidata dai dati poiché identifica modelli nei dati esistenti per prevedere le proprietà di un input sconosciuto ma simile. Nel gennaio 2020, Curative Enzymes, un fornitore di prodotti e servizi, ha lanciato il servizio di ingegneria e modifica degli enzimi per aiutare i principali clienti.

Con l'emergere di nuove tecniche e metodi per ricostruire e ingegnerizzare gli enzimi, lavorando nell'ingegneria delle proteine è diventato più conveniente, mettendo in luce nuovi biocatalizzatori e molecole semisintetici o sintetici per applicazioni industriali. Pertanto, è probabile che i progressi nell'ingegneria enzimatica costituiscano una tendenza prevalente nel mercato durante il periodo di previsione.

Approfondimenti basati sul tipo di enzima

Il mercato della tecnologia degli enzimi medici, per tipo di enzima, è segmentato in enzimi digestivi, enzimi trombolitici, idrolasi ed endonucleasi. Il segmento delle idrolasi ha detenuto la quota maggiore del mercato nel 2020; inoltre, si prevede che il segmento degli enzimi trombolitici registrerà il CAGR più elevato del 7,2% sul mercato durante il periodo di previsione.


Mercato della tecnologia degli enzimi medici, per tipo di enzima: 2020 e 2028


Approfondimenti basati sull'applicazione

Il mercato della tecnologia degli enzimi medici, per applicazione, è segmentato in trattamento delle malattie, strumenti diagnostici , ricerca biomedica e altri. Il segmento del trattamento delle malattie ha detenuto la quota maggiore del mercato nel 2020 e si prevede che lo stesso segmento registrerà il CAGR più elevato del 7,1% nel mercato durante il periodo di previsione.

Approfondimenti strategici

< p>Le aziende che operano nel mercato della tecnologia degli enzimi medici stanno adottando strategie organiche come il lancio di prodotti e l'espansione per espandere la propria presenza e il portafoglio di prodotti in tutto il mondo, nonché per soddisfare le crescenti richieste.

Per tipo di enzima

  • Enzima digestivo
  • L-asparaginasi
  • Lattasi
  • Altri
  • Enzima trombolitico
  • Streptochinasi
  • Urochinasi
  • Altri
  • Enzima idrolasi
  • Ialuronidasi
  • Lisozimi
  • Altri
  • Endonucleasi Enzimi
  • Benzonasi
  • Altri

Per applicazione

  • Trattamenti per le malattie
  • Strumenti diagnostici
  • Ricerca biomedica
  • Altro

Per geografia

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto d'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia< /li>
    • Resto dell'APAC
  • Medio Oriente e Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del MEA
  • America centrale e meridionale (SCAM)
    • Brasile
    • < li>Argentina
    • Resto delle truffe

Profili aziendali

  • Merck
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Agilent Technologies, Inc.
  • Danaher (Cytiva)
  • Sanofi
  • Asahi Kasei Corporation
  • Promega Corporation
  • Amano Enzyme Inc
  • < li>Genzyme Corporation
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Medical Enzyme Technology?

Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly.

What are the driving factors for the Medical Enzyme Technology market across the globe?

Key factors that are driving the market are advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.

What is the cost of Medical Enzyme Technology?

The costs of the Medical Enzyme Technology are much higher, and they may cost US$ 5–50, or more, per enzyme type. The cost may also differ from product to product types.

The List of Companies - Medical Enzyme Technology Market

  1. Merck
  2. Thermo Fisher Scientific Inc.
  3. Novozymes
  4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
  5. Agilent Technologies, Inc.
  6. Danaher (Cytiva)
  7. Sanofi
  8. Asahi Kasei Corporation
  9. Promega Corporation
  10. Amano Enzyme Inc
  11. Genzyme Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports